At the end of March, RGDX reportedly had $5 million of cash and cash equivalents. I believe they lost a little over three mil the last quarter. Cash could be a problem going forward unless sales have ramped up. Judging by the share price action of late, I get the feeling that this quarter may reveal a definite need for raising money. I guess a collaboration or a sale of the company would be desirable, but diluting shares could cause longs a lot of pain. IMHO.
I imagine the effect of any good news will be exaggerated to the upside with the large (but getting smaller) short position. I don't like to see anyone lose money, but I don't have much sympathy for those who are hoping for a stock to go down, especially bio-techs which hold so much hope for people with various illnesses. Oh well, its a betting game, and we all place our bets and take our chances. My ace in the hole is Dr. Frost who seems to be buying 100,000's of shares on a monthly basis. A relative of mine worked with Dr. Frost years ago, and he told me he is a very astute and knowledgeable person. Makes sense to be long for me as long as he keeps buying. If Dr. Frost just says he is exploring strategic options for OPK, I predict the stock will shoot up dramatically. IMHO.
I imagine the trend is continuing into July based on the stock movement and Frost's continued buying. Don't know why anyone would not cover at this point, but hey, there are always two sides to every stock. Today is a down day, but OPK is more than holding its own. If the reports are true about the drop in short interest, it looks like the smart shorts are covering and heading for safer plays. IMHO.
Frost has been buying thousands of shares a few times every week no matter the price. Little by little, the guy will own the company outright. Every time he buys should make the shorts shudder. All he has to do is announce that he is seeking strategic options for OPK, and he would toast shorts.
You have to love this guy. But then, he knows what is going on, so buying when you know the investment is good is a no brainer!
Actually, I have never seen such an avid short group on a message board. Their sentiments don't seem to affect OPK's stock price as it is strong on good volume on a blah day. If OPK has some positive comments at its upcoming conference call, all this short pressure should really propel the stock much higher. Might be time for shorts to pull their thumbs out of their mouths and cover. Pretty soon the short float will have to cover as Dr. Frost relentlessly continues to buy up hundreds of thousands of shares on a regular basis. IMHO.
Today's newspaper just reported that intelligence officials said that our government offered to help deal with ISIS before they gained their foothold, but Iraq said they could handle it themselves. Bush went into Iraq on his nation building expedition. The only problem is that sometimes you prop up governments that don't care that you spent billions of dollars and countless lives fighting for their freedom. Even though Frank and others believe we can just inflict our will on other nations, it doesn't work that way. They way I see it is let the Iraqis fend for themselves. If they value their freedom, they should fight like heck to preserve it. If they aren't willing to do that, I will never support keeping our young men and women and our tax dollars there because a country of wimpy cowards will never survive.
I agree with your assessment of CEMP. I hold a decent chunk though the stock got hit with the recent biotech pullback. If Solithromycin is as good as they say, CEMP should do very well upon approval.
I think the faint of heart are getting nervous with all of Frost's purchases and coming news. OPK has survived the biotech blood bath, so that tells me that there is a lot of support in place. OPK has a lot of irons in the fire, so the possibility of positive news increases with every passing day. The biotech analyst on CNBC yesterday seemed to think OPK was a biotech worth mentioning. IMHO.
I am not qualified to comment on the validity of the science of each of the companies, but NWBO's one year chart sure looks nicer than CLDX's. That could change dramatically for better or worse with one press release though. Just the nature of biotech!
Analyst was pretty positive about OPK and its prospects. With Frost buying so many shares every week, it sure looks like something very good is in the near future. With so many shorts needing to cover on positive news, this stock could really skyrocket. IMHO.
Maybe we will hear something good at the upcoming earnings announcement. Everything I have read so far about their trial results has been positive, so I hope we get some good news. I too started buying when the stock was higher. I guess my cost is in the 10's. If we get good news, I believe the stock will bounce much higher than that. IMHO.
Way over 3 million now. Someone seems to have a very big interest in TRQ. Maybe progress is being made with the government.
indirectly through entities he controls. This guy is either throwing his money away, or he knows that this investment is the best one he can make. If I was short, I would run to cover!!! IMHO.
I don't see the big reason to short OPK. They have late stage drugs in development, and they have worldwide sales of various drugs that bring in decent revenue. With Frost appearing to be buying hundreds of thousands of shares hand over fist, shorts could be in for a big hurt. Seems like there are much better shares to short in my opinion.
He seems to be buying shares like crazy. Now if his name was Icahn, Opk would be selling in the twenties. I actually think Frost is much smarter than CI, especially when it comes to drug companies. Good luck.